Renaissance Technologies (RenTech)'s ARCT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 178,300 shares of Arcturus Therapeutics Holdings Inc. (ARCT) worth $1.38 M, representing 0.00% of the portfolio. First purchased in 2019-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ARCT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 265,700 shares. Largest reduction occurred in Q4 2023, reducing 169,498 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Arcturus Therapeutics Holdings (ARCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arcturus Therapeutics Holdings (ARCT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +58,395 | Add 48.70% | 178,300 | $7.72 |
| Q4 2025 | +119,905 | New Buy | 119,905 | $6.13 |
| Q1 2024 | -10,202 | Sold Out | 0 | $0.00 |
| Q4 2023 | -169,498 | Reduce 94.32% | 10,202 | $31.56 |
| Q3 2023 | -86,000 | Reduce 32.37% | 179,700 | $25.55 |
| Q2 2023 | +265,700 | New Buy | 265,700 | $0.03 |
| Q1 2022 | -26,687 | Sold Out | 0 | $0.00 |
| Q4 2021 | +26,687 | New Buy | 26,687 | $37.02 |
| Q3 2021 | -29,500 | Sold Out | 0 | $0.00 |
| Q2 2021 | -113,300 | Reduce 79.34% | 29,500 | $33.83 |
| Q1 2021 | +142,800 | New Buy | 142,800 | $41.30 |
| Q1 2020 | -23,300 | Sold Out | 0 | $0.00 |
| Q4 2019 | -9,200 | Reduce 28.31% | 23,300 | $10.86 |
| Q3 2019 | +32,500 | New Buy | 32,500 | $10.28 |
Renaissance Technologies (RenTech)'s Arcturus Therapeutics Holdings Investment FAQs
Renaissance Technologies (RenTech) first purchased Arcturus Therapeutics Holdings Inc. (ARCT) in Q3 2019, acquiring 32,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Arcturus Therapeutics Holdings Inc. (ARCT) for 14 quarters since Q3 2019.
Renaissance Technologies (RenTech)'s largest addition to Arcturus Therapeutics Holdings Inc. (ARCT) was in Q2 2023, adding 265,700 shares worth $7,620.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 178,300 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $1.38 M.
As of the Q1 2026 filing, Arcturus Therapeutics Holdings Inc. (ARCT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Arcturus Therapeutics Holdings Inc. (ARCT) was 265,700 shares, as reported at the end of Q2 2023.